Pulse Biosciences Schedules Fourth Quarter & Full Year 2024 Financial Results Conference Call for March 27, 2025
Pulse Biosciences (Nasdaq: PLSE), specializing in Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, has scheduled its Fourth Quarter and Full Year 2024 financial results announcement for March 27, 2025, after market close.
The company will host a conference call at 1:30pm PT / 4:30pm ET on the same day. Investors can participate by dialing 1-888-596-4144 with conference ID 5548579. A live and recorded webcast will be available on the company's investor website.
Pulse Biosciences (Nasdaq: PLSE), specializzata nella tecnologia di ablazione a campo pulsato in nanosecondi™ (nsPFA™), ha programmato l'annuncio dei suoi risultati finanziari del quarto trimestre e dell'intero anno 2024 per il 27 marzo 2025, dopo la chiusura del mercato.
L'azienda ospiterà una chiamata in conferenza alle 13:30 PT / 16:30 ET dello stesso giorno. Gli investitori possono partecipare componendo il numero 1-888-596-4144 con l'ID conferenza 5548579. Un webcast in diretta e registrato sarà disponibile sul sito web per gli investitori dell'azienda.
Pulse Biosciences (Nasdaq: PLSE), especializada en la tecnología de ablación por campo pulsado en nanosegundos™ (nsPFA™), ha programado el anuncio de sus resultados financieros del cuarto trimestre y del año completo 2024 para el 27 de marzo de 2025, después del cierre del mercado.
La compañía realizará una llamada de conferencia a las 1:30 p.m. PT / 4:30 p.m. ET el mismo día. Los inversores pueden participar marcando el 1-888-596-4144 con el ID de conferencia 5548579. Se dispondrá de una transmisión web en vivo y grabada en el sitio web para inversores de la compañía.
펄스 바이오사이언스(Pulse Biosciences) (Nasdaq: PLSE)는 나노초 펄스 필드 절제 기술™ (nsPFA™)에 전문화되어 있으며, 2024년 4분기 및 연간 재무 결과 발표를 2025년 3월 27일에 시장 마감 후로 예정하고 있습니다.
회사는 같은 날 오후 1시 30분 PT / 오후 4시 30분 ET에 컨퍼런스 콜을 개최합니다. 투자자들은 1-888-596-4144로 전화하여 회의 ID 5548579를 입력하여 참여할 수 있습니다. 회사의 투자자 웹사이트에서 실시간 및 녹화된 웹캐스트를 이용할 수 있습니다.
Pulse Biosciences (Nasdaq: PLSE), spécialisée dans la technologie d'ablation par champ pulsé en nanosecondes™ (nsPFA™), a prévu l'annonce de ses résultats financiers du quatrième trimestre et de l'année complète 2024 pour le 27 mars 2025, après la fermeture du marché.
La société organisera une conférence téléphonique à 13h30 PT / 16h30 ET le même jour. Les investisseurs peuvent participer en composant le 1-888-596-4144 avec l'ID de conférence 5548579. Un webcast en direct et enregistré sera disponible sur le site web des investisseurs de l'entreprise.
Pulse Biosciences (Nasdaq: PLSE), spezialisiert auf Nanosekunden-Pulsfeld-Ablation™ (nsPFA™) Technologie, hat die Bekanntgabe ihrer Finanzergebnisse für das vierte Quartal und das Gesamtjahr 2024 für den 27. März 2025 nach Marktschluss angesetzt.
Das Unternehmen wird am selben Tag um 13:30 Uhr PT / 16:30 Uhr ET eine Telefonkonferenz veranstalten. Investoren können teilnehmen, indem sie 1-888-596-4144 mit der Konferenz-ID 5548579 anrufen. Ein Live- und aufgezeichnetes Webcast wird auf der Investorenseite des Unternehmens verfügbar sein.
- None.
- None.
Investors interested in listening to the conference call may do so by dialing 1-888-596-4144 and providing conference ID 5548579. A live and recorded webcast of the event will be available on the Pulse Biosciences Investors website at http://investors.pulsebiosciences.com/.
About Pulse Biosciences®
Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the intention as well as the potential to improve the quality of life for patients. The Company’s proprietary CellFX® nsPFA™ technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is actively pursuing the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers.
Pulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS, nsPFA, CellFX nsPFA and the stylized logos are among the trademarks and/or registered trademarks of Pulse Biosciences, Inc. in
View source version on businesswire.com: https://www.businesswire.com/news/home/20250307031819/en/
Investors:
Pulse Biosciences, Inc.
Jon Skinner, CFO
IR@pulsebiosciences.com
Or
Gilmartin Group
Philip Trip Taylor
415.937.5406
philip@gilmartinir.com
Source: Pulse Biosciences, Inc.
FAQ
When will Pulse Biosciences (PLSE) release its Q4 and FY 2024 earnings?
How can investors join Pulse Biosciences (PLSE) Q4 2024 earnings call?
What time is Pulse Biosciences (PLSE) Q4 2024 earnings conference call?
What is Pulse Biosciences' (PLSE) main technology focus?
